INTRODUCTION:

Process analytical technology, or PAT, has become a crucial strategy in the pharmaceutical sector, transforming the creation and production of medications. PAT has helped pharmaceutical companies increase product quality, process efficiency, and regulatory compliance by combining sophisticated analytical techniques, real-time monitoring, and data-driven decision-making¹. An outline of PAT's importance and how it has changed pharmaceutical development and production will be given in this introduction section.

A regulatory framework for the use of PAT has been provided by the FDA. With this framework, "the FDA tries to motivate the pharmaceutical industry to improve the production process," according to Hinz.

The manufacturing technology is "frozen" when phase-2 clinical trials are being conducted due to the stringent regulatory requirements and the protracted drug.³

Pharmaceutical PAT:

Multivariate calibration chemometrics and advanced data preprocessing mathematics are necessary for near-infrared applications. The application of robust and flexible Fiber-optical probes has greatly benefited this technique. Due to the Fibers’ poor stability and lack of robustness, a similar method for mid-IR has not yet been developed. According to recent research, a recently created miniature diamond ATRprobe with strong Fiber optics and high chemical and pressure resistance is being used. The monitoring of a solventless reaction on a Liter scale and the regular and practical application in a glovebox to extremely oxygen-and air-sensitive reactions on a millilitres scale are reported.^1,2

Fig.No.1 Fundamentals of Process Analytical Technology (PAT)

1. Definition of PAT:

The Food and Drug Administration (FDA) of the United States defines process analytical technology (PAT) as "a mechanism to design, analyze, and control pharmaceutical manufacturing processes through the measurement of Critical Process Parameters (CPP) which affect Critical Quality Attributes (CQA)".³

Pharmaceutical and biopharmaceutical products must be of the highest quality. The FDA's quality-by-design (QbD) and process analytical technology (PAT) paradigms encourage manufacturers to continuously monitor process streams and unit operations in order to guarantee consistency in product quality. For continuous process verification in thepharmaceutical production process, PAT is acknowledged as a crucial and fundamental change in the inspection and approval processes. The Center for Drug Evaluation and Research (CDER) of the FDA has recognized the necessity of FDA guidelines to facilitate the implementation of PAT.⁴

Real-time Monitoring:

Process parameters are continuously monitored as part of PAT in order to obtain real-time insights into the ongoing production.⁴

Multivariate Analysis:

PAT uses sophisticated data analysis methods, such chemometrics, to glean valuable insights from intricate datasets.⁴

Quality by Design (QbD):

PAT establishes a reliable manufacturing process that reliably produces goods with the required quality attributes by aligning with QbD principles.⁴

Continuous Improvement:

PAT makes it possible for manufacturers to use a data-driven approach to find process variances and apply changes for increased productivity and quality.⁴

Principles of PAT Implementation and Integration:

When developing new chemical processes, there are numerous chances to employ different techniques for process understanding and control, such as formulation development, API crystallization, isolation, and drying, or the progression and kinetics of chemical reactions. Using in-situ analytical tools during development is becoming more common as industry expects higher quality products and more aggressive development timeframes. Applying process analytical technology (PAT) earlier in the product development cycle allows for greater process understanding, which is one of its advantages.⁵

Applications of PAT:

Information about Continuous Flow Chemistry is provided by Process Analytical Technology (PAT).³⁶

· Crystallization and precipitation

· Raman Spectroscopy

· Formulation And Development

· Fermentation And Bioprocessing

· PAT For Chemical Reaction

· Monitoring of the inline drying process in FBD

· Equipment condition during inline cleaning using TOC or UPLC

FTNIR OR Raman spectroscopy is used to analyze the uniform distribution of components in a cone blender or mixer in real time.³⁶

Typical industries include life sciences, chemicals, cosmetics, and oli gas. If you regularly produce high-quality, high-value products, PAT will be very beneficial to your process and improve the food and pharmaceutical industries.⁴

Fig.No.2: Quality by Design Steps

Quality by Design Steps:

The first step in the quality and design examine is to identify the product's intended function and the appropriate quality to address that objective; the second step involves evaluating the scientific data and information required to define the critical quality traits; the next step involves evaluating the development of procedures with concepts like experimental design, process analytical technology, and risk control; additionally, a design area is established to ensure quality in this step; the next step involves identifying and designing the control strategy; and the final step provides continual enhancement and life cycle through the integration of product process knowledge and risk management for quality.⁷

Univariate experiments in the standard pharmaceutical development process are focused on reproducibility, whereas structured trials that are highly variable in design and quality carry out in a design area and focused on the control strategy; however, in the traditional approach, the control plan is primarily composed of intermediary and finished product tests, whereas in the design approach, the controls are made in the stage of manufacturing and real-time release is the case; furthermore, process control is carried out with an off the grid analysis in the traditional approach, while PAT is used in design and quality comprehension.^8,10,11

Fig.No.3 Process Analytical Technology Steps:

Process Analytical Technology

PAT is comprised of three primary steps: design, analysis, and control (Figure 2). At the design step, the level of effects of every step in the process and the starting point must be determined in order to mine the quality of the final product. In the testing step, direct or indirect analytical methods are used in real time to establish the high-quality characteristics of the process materials and raw material. Lastly, in the final step, the alignment between all the results obtained through a process control is evaluated.^10,12

PAT = Process understanding:

· The identification and explanation of all significant causes of variability improves the understanding of a process.

· The process controls variability.

· Product quality attributes can be accurately and consistently anticipated.

Process understanding is reflected in accurate and dependable predictions. Process comprehension and risk are adversely correlated.⁹

Strategy for PAT Implementation:

The Agency recognizes that flexibility, coordination, and communication with makers are essential for an effective implementation of PAT. The Agency feels that the laws in place are sufficiently expansive to allow for these tactics.¹⁴

When there is meaningful, efficient, and transparent communication between the Agency and industry—for instance, through meetings or unofficial communications—regulations can effectively foster innovation.

The first part of the PAT framework, which was previously mentioned, covers a lot of the unknowns surrounding innovation and provides general guidelines for dealing with upcoming scientific and technical problems. A manufacturer should use this framework to help them propose and implement novel production and quality assurance. The Agency has created a regulatory strategy to take such recommendations into consideration and supports them. The Agency's regulatory strategy includes the following:

· A PAT team strategy for current Good Manufacturing Practices (cGMP)

· audits and CMC reviews.

· Personnel involved in PAT review, inspection, and compliance get joint education and certification.

· Technical as well as scientific assistance for the PAT review, inspection, and compliance staff.⁶

Fig.No.4: Control Strategy for PAT Application

Control Strategy for PAT Application:

During the manufacturing process, appropriate control measures should be used to manage variables that impact the quality of the final product. Understanding products, procedures, and risk management leads to a control approach. There are several methods, including RTRT, in-process testing, and finished product testing.^15,16,17

The QbD technique uses each variable, production environment, and other circumstances to accurately and reliably anticipate product-quality attributes within the defined design space.¹⁸ Control strategies are goods to create consistent quality that satisfy the required quality attributes since this advances our understanding of products and processes.^19,20

The Effect of the Manufacturing Process on Intermediates during Processing:

According to the above description, CPV was implemented in the pharmaceutical sector to ensure that high-quality medications are produced throughout the drug lifecycle through quality assurance and control. Consequently, in CPV, the assessment of intermediate quality and process monitoring QbD is used to determine the quality of intermediate goods that could impact the quality of final products, and the PAT framework is used to modify process parameters during manufacture.^18,21,22

Work flow of PAT Framework for the Pharmaceutical Manufacturing Process:

It is essential to comprehend the procedure, the resources, and the features of the PAT tool before implementing it. For the PAT process, the most suitable PAT tool is chosen and used. This process involves elements like the location of the Measurement technique and PAT tool should be taken into account. PAT measuring techniques are divided into three categories: online, on-line, and in-line. A measurement technique called the "at-line method" gathers, separates, and examines a sample from a location that is extremely near to the process. A sample is tested during the manufacturing process, its appropriateness is assessed, and it is then returned to the processor and rejected using the online measurement method. Using software for in-line real-time monitoring without taking a sample out of the process flow²³The process is then monitored, and statistical techniques are used to analyse and assess the data that was gathered. Preprocessing technologies, chemometric modeling, and data interpretation are the three categories into which statistical approaches can be separated. In the preprocessing step, standard normal variate (SNV), multiplicative scatter correction (MSC), and derivative store Duce data are used to provide accurate data and reduce data interference.^24,25,26 To validate the relationship between CQAs, critical material attributes (CMAs), and CPPs, chemometric modeling employs partial least square (PLS), principal component analysis (PCA), multiple linear regression (MLR), etc. ^27,28 The purpose of data evaluation is to quantify and improve data predictability through the use of metrics such as root mean square error of prediction (RMSEP) and root mean square error of calibration (RMSEC).^29,30 PAT is used in this manner in a variety of provided books. It is suggested that using PAT to measure the quality of intermediate and final products in RTRT during the process can help with both process and quality management.

As Shown in figure, CPV and QbD approaches to the production of high-quality drug products depend on PAT. In lab-scale drug development, QTPP and risk assessment are used to identify CMAs, CPPs, and CQAs in the formulation and process, DoE is used to derive an optimal design space, and multivariate analysis (MVA) based on QbD is used to identify correlations with CQAs, CPPs, and IQAs.³¹By using PAT to examine process variability in real-time throughout the commercial/pilot scale, process and quality control are made possible based on the correlation between CQAs, CPPs, and IQAs. the production process. Because PAT improves process comprehension through realtime process monitoring and facilitates quick detection and response, it is employed as a control method for RTRT in the pharmaceutical manufacturing process when it is introduced into the QbD approach.^15,32,33

In other words, CPV is made possible by executing RTRT using PAT application in real time to control the correlation found using the QbD technique, which results in the manufacture of premium drug items with guaranteed qualifying the product at every stage of production.

PAT Tools for the Pharmaceutical Manufacturing Process:

1) UV visible spectroscopy:

Measuring the active ingredient in pharmaceutical injectable formulations is a more cost-effective, time-efficient, and advantageous technique for measuring lysine clonixinate.¹³

2) Mass Spectroscopy:

A very helpful PAT instrument for the qualitative examination of drugs, compounds, and related substances is Mass Spectroscopy. It is also utilized in the qualitative analysis of tiny molecules and is frequently chosen and employed in biological processes because to its high resolution and mass accuracy. as in the examination of diverse biomolecules.^34,35 Additionally, when automated data processing and high throughput sample preparation are feasible, it offers speedy analysis. ^[37]The mass spectrum gives the precise molecular weight or molecular formula to show the presence of a certain structural feature and is frequently used to determine the identity of two compounds or the structure of a new chemical. molecule's unit. The primary benefit of mass spectrometry is its capacity to test a wide variety of substances with superior discrimination in a remarkably brief amount of analytical time. Additionally, it is employed to uncover the structure and chemical characteristics of additional molecules as well as to quantitatively assess recognized substances or detect novel compounds in a sample. MS requires the sample to be vaporized and ionized, as well as the maintenance of a vacuum. Therefore, if a sample cannot be broken down and evaporated, it cannot be analyzed, which is the drawback of MS. Real-time drying process management, in particular the tracking of trace levels of organic solvents utilized in the creation of intermediate and final products, is one of the common uses for MS.⁸

3) Near-Infrared Spectroscopy (NIRS):

Numerous research has used NIRS as a practical spectral analysis tool since its discovery by Herschel in the 1800s. The transmittance and reflectance produced by molecular vibrational motion utilizing light are the basis of NIRS, a qualitative and quantitative analysisin the 780–2800 nm area of the near-infrared spectrum. The pharmaceutical business uses it most frequently as a real-time process monitoring tool for processing quality assurance and product quality control.^15,20,38 Quality control through real-time monitoring is feasible when the NIRS is coupled to a Fiber optic probe. The transmission and reflection of the NIRS by the sample allows for non-destructive measurement of the product's quality during the process.¹⁹A corrosion-resistant substance makes up the probe's exterior, while an optical Fiber, lens, mirror, and signal channel make up its interior. Because of its sapphire window connection, it can function well even in subpar processing circumstances. When the probe is attached to the NIR spectrometer, the focusing lens concentrates the light coming from the light source. A sample is reflected, transferring the light reflected by the probe's tip mirror to the near-infrared spectrum. Through computer software linked to the NIR spectrometer, the transmitted signal is transformed into a spectrum. However, because the absorption bands overlap because of spectrum overlap, NIRS has the drawback of being more difficult to interpret than traditional analysis techniques like chromatography, ultraviolet/visible (UV-VIS) light, and others. complexity. A reference method must be used to create and validate an accurate corrective model because this is a relative approach.²⁸

4) Raman Spectroscopy:

Similar to NIRS, Optical fibers are used in the noncontact analytical technique known as Raman spectroscopy.³⁹ Vibration spectroscopy includes Raman spectroscopy. From the UV-VIS to the near-infrared, different Raman laser sources provide a range of wavelengths (usually 785 nm); visible light lasers are the most widely used.⁴⁰Raman spectroscopy is highly utilized in pharmaceutical manufacturing because it allows for the quick characterization of the chemical composition and structure of a solid, liquid, gas, gel, or powder sample by providing the specific characteristics of their vibrational transitions. Generally speaking, vibrations occur in chemical bonds that are not rigid, and materials can be described based on their molecular-vibration frequencies^.41 The drug content of a given sample can be calculated using Raman spectroscopy, which is used to identify the molecules present in the sample and measure their intensity. Developing and improving quality is one of the primary goals of PAT. Examine the raw material spectrum's specificity library, taking into account any sample contaminants.⁴⁰

5) X-ray Fluorescence (XRF):

Components of various sample types, such as solids, liquids, slurries, and powders, can be identified using XRF, an atomic analysis technique that works similarly to atomic absorption and inductively coupled plasma light atomic emission spectroscopy (ICP-AES). AAS, or spectroscopy. The pharmaceutical sector uses AAS and ICP-AES extensively for atomic high-sensitivity analysis due to their ability to quantify more than 70 distinct elements. However, because of the acid-decomposition process, sample preparation takes longer, and the cathode lamp can only analyze a certain analyte. Furthermore, the high maintenance costs and significant area required are clear drawbacks. XRF was created as a substitute.⁴²The transfer of internal electrons and the interaction of X-ray radiation with atoms are the foundations of the chemical analysis technique known as XRF. When electrons in high-energy atoms are attacked by high-energy X-rays, they are released.²⁷ Because of the energy difference between the two, a vacancy is therefore formed in the inner shell, and electrons in the outer orbit are transported to cover the vacancy, producing fluorescent X-rays. orbits. Because every element contains an electron with a distinct energy level, elemental analysis is made feasible by the distinct energy difference brought about by the distinctive X-ray irradiation.⁴³Thus, the advantages of XRF are low overlap, high selectivity, and a limited number of gathered spectra.⁴⁴

6) Acoustic Resonance Spectrometry (ARS):

The sound produced during the pharmaceutical procedure is detected and analysed by the ARSasaPAT application. The frequencies at which ARS detects sound are significantly higher than those that the human ear can detect.⁴⁵In addition to pulverization, fluidized-bed granulation, and chemical reaction testing or blending, it is typically used in procedures that produce sonic emission. For instance, when particles are granulated, they release When they clash and create friction in the machinery, different noises are produced. Like the majority of PAT instruments, ARS is non-invasive, doesn't require sample preparation, and has the benefit of being a convenient and affordable application technique. Quantitative data, including moisture content and particle properties, can be acquired using sonic emission. It is possible to track changes in the powder's physical features, including its distribution and compression characteristics. ARS was utilized by Tsujimoto et al. to track and describe particle motion brought on by friction. Through the association between ARS and particle mobility, they were also able to observe particle behaviour during the fluidized-bed granulation process. The collected sound was amplified and the sensitivity was adjusted to examine the frequency when an ARS was placed at the bottom of the fluidized-bed granulator. As the fluidized-bed granulator's rotational speed increased, the impact of particles striking the chamber wall increased as well, which in turn caused the AE amplitude to grow. Furthermore, the instability brought on by the ARS was able to identify a rise in the volume of spray solution, or a higher moisture content, during the fluidized-bed granulation process.^45,46

CONCLUSION:

PAT is not just a technological upgrade but a strategic enabler for achieving high product quality, faster time-to-market, and global regulatory compliance. Its adoption marks a significant shift toward intelligent, automated, and quality-centric manufacturing systems in the pharmaceutical industry.

REFERENCES:

1. FDA, Guidance For Industry: PAT – a framework for innovative pharmaceutical development, manufacturing and quality assurance. September 2004.

2. Arti Swami, Shivani Chakankar, Prajakta Chavan. A critical review on recently used pat in pharmaceutical industry. RJPT

3. Rakshit V Thumar, Vidhi N Kalola, Nishendu P Nadpara, Parula B Patel. A complete review of process analytical technology. Int J Pharm Sci Rev Res. 2012; 17; 57-65.

4. Bakeev KA. Near-infrared spectroscopy as a process analytical tool. Part ii. Atline and on-line applications and implementation strategies. Spectroscopy 2004

5. Anurag S. Rathod, Naveen Gjesubalan. Perspectives on process analytical technology. Bio Pharm International. May 2022; 35(5): 31–35

6. Akash S. Mali, Monali Jagtap, P Karekar, A Maruška. A brief review on process analytical technology (PAT). International Journal of Current Pharmaceutical Res. 8(1): 10-15

7. Minnich, C. B.; Buskens, P.; Steffens, H. C.; B¨Auerlein, P. S.; Butvina, L. N.; Ku¨Pper, L.; Leitner, W.; Liauw, M. A.; Greiner, L. Org. Process Res. Dev. 2007; 11(1): 94–97.

8. Aarti Shastri, Kajal Dhumal, Aishwarya Patil, Dipali Sawant, Swarupa Hatolkar. Process analytical technology (PAT): Enhancing quality and efficiency in pharmaceutical development and production. Journal For Reattach Therapy and Developmental Diversities. 6(1): 1963-1973.

9. Katherine A. Bakeev, Jun Chen, Gregory J. Process analytical technology (PAT): Use from development through implementation in the pharmaceutical industry.

10. Poonam Ingalwad, Vikram Veer, Ashok Bhosale and Nayna Khedekar. Illustrative review on process analytical technology. World Journal of Pharmaceutical Research. 6: 760-769.

11. Selda Dogan Calhan, Ebru Derici Eker and Nefise Ozlen Sahin. Quality by design (QBD) and process analytical technology (PAT) applications in pharmaceutical industry. European Journal of Chemistry. 2017; 8(4): 430‐433

12. Mike, F.; Bozdag, P. S.; Oner, L. Hacettepe. Univ. J. Fac. Pharm. 2013; 33(2): 203‐230.

13. Zhang, L.; Mao, S. Asian J. Pharm. Sci. 2017; 12(1): 1‐8.

14. Poonam Ingalwad, Vikram Veer, Ashok Bhosale. Illustrative review on process analytical technology. World Journal of Pharmaceutical Research. 9(6): 760-769.

15. Jaydeep Ganguly, Gerrit Vogel. 'Process Analytical Technology. J Int Soc Pharm Eng. 2006; 26: 1-9.

16. Goodwin, D.J.; Van Den Ban, S.; Denham, M.; Barylski, I. Real time release testing of tablet content and content uniformity. Int. J. Pharm. 2018; 537: 183–192.

17. Dasu, M.; Naresh, J.R. Real time release testing-a new quality paradigm for pharmaceutical development. Int. J. Pharm. Sci. Rev. Res. 2013; 19: 80–84.

18. Devi, N.G.; Chandramouli, R. Real time release testing-a review. J. Pharm. Res. 2018; 16: 314–318.

19. Panzitta, M.; Calamassi, N.; Sabatini, C.; Grassi, M.; Spagnoli, C.; Vizzini, V.; Ricchiuto, E.; Venturini, A.; Brogi, A.; Font, J.B. Spectrophotometry and pharmaceutical PAT/RTRT: Practical challenges and regulatory landscape from development to product lifecycle. Int. J. Pharm. 2021; 601: 120551.

20. Puchert, T.; Holzhauer, C.-V.; Menezes, J.; Lochmann, D.; Reich, G. A new PAT/QBD approach for the determination of blend homogeneity: combination of on-line nirs analysis with pc scores distance analysis (PC-SDA). Eur. J. Pharm. Biopharm. 2011; 78: 173–182.

21. Jain, S. Quality by design (QBD): a comprehensive understanding of implementation and challenges in pharmaceuticals development. Int. J. Pharm. Pharm. Sci. 2014; 6: 29–35.

22. Araújo, A.S.; Andrade, D.F.; Babos, D.V.; Pricylla, J.; Castro, J.A.G.; Sperança, M.A.; Gamela, R.R.; Machado, R.C.; Costa, V.C.; Guedes, W.N. Key information related to quality by design (qbd) applications in analytical methods development. Braz. J. Anal. Chem. 2021; 8: 14–28.

23. Patil, A.S.; Pethe, A.M. Quality by design (QBD): a new concept for development of quality pharmaceuticals. Int. J. Pharm. Qual. Assur. 2013; 4: 13–19.

24. US Food and Drug Administration. Guidance for industry, pat-a framework for innovative pharmaceutical development, manufacturing and quality assurance. 2004. Available online: http://www.fda.gov/cder/guidance/published.html (accessed on 10 march 2021).

25. Engelsen, S.B.; Mikkelsen, E.; Munck, L. New approaches to rapid spectroscopic evaluation of properties in pectic polymers. In the colloid science of lipids; Springer: Berlin, Germany, 1998; pp. 166–174.

26. Rinnan, A.; Van Den Berg, F.; Engelsen, S.B. Review of the most common pre-processing techniques for near-infrared spectra. Trends Analytical Chem. 2009; 28: 1201–1222.

27. Reimers, T.; Thies, J.; Stöckel, P.; Dietrich, S.; Pein-Hackelbusch, M.; Quodbach, J. Implementation of real-time and in-line feedback control for a fluid bed granulation process. Int. J. Pharm. 2019; 567: 118452.

28. Panchuk, V.; Yaroshenko, I.; Legin, A.; Semenov, V.; Kirsanov, D. Application of Chemometric methods to XRF-Data–a Tutorial review. Anal. Chim. Acta. 2018; 1040: 19–32.

29. Blanco, M.; Villarroya, I. NIR Spectroscopy: a rapid-response analytical tool. Trends Analytical Chem. 2002; 21: 240–250.

30. Cozzolino, D.; Cynkar, W.; Shah, N.; Smith, P. Multivariate data analysis applied to spectroscopy: potential application to juice and fruit quality. Food Res. Int. 2011; 44: 1888–1896.

31. Cronin, M.T.; Schultz, T.W. Pitfalls in QSAR. J. Mol. Struct. Theochem. 2003; 622: 39–51.

32. Kim, J.Y.; Chun, M.H.; Choi, D.H. Control strategy for process development of high-shear wet granulation and roller compaction to prepare a combination drug using integrated quality by design. Pharmaceutics. 2021; 13: 80.

33. Pauli, V.; Roggo, Y.; Pellegatti, L.; Trung, N.Q.N.; Elbaz, F.; Ensslin, S.; Kleinebudde, P.; Krumme, M. Process analytical technology for continuous manufacturing tableting processing: a case study. J. Pharm. Biomed. An. 2019; 162: 101–111.

34. Jiang, M.; Severson, K.A.; Love, J.C.; Madden, H.; Swann, P.; Zang, L.; Braatz, R.D. Opportunities and challenges of real-time release testing in biopharmaceutical manufacturing. Biotechnology. 2017; 114: 2445–2456.

35. Zeng, S.; Wang, L.; Chen, T.; Wang, Y.; Mo, H.; Qu, H. Direct analysis in real time mass spectrometry and multivariate data analysis: a novel approach to rapid identification of analytical markers for quality control of traditional Chinese medicine preparation. Anal. Chim. Acta. 2012; 733: 38–47.

36. De beer, T.; Allesø, M.; Goethals, F.; Coppens, A.; Vander Heyden, Y.; Lopez de Diego, H.; Rantanen, J.; Verpoort, F.; Vervaet, C.; Remon, J.P. Implementation of a process analytical technology system in a freeze-drying process using raman spectroscopy for in-line process monitoring. Anal. Chem. 2007; 79: 7992–8003.

37. Eun Ji Kim, Ji Hyeon Kim, Min-Soo Kim. Process analytical technology tools for monitoring pharmaceutical unit operations: a control strategy for continuous process verification, MDPI Journals, Basel, Switzerland.

38. Reddy, J.P.; Jones, J.W.; Wray, P.S.; Dennis, A.B.; Brown, J.; Timmins, P. Monitoring of multiple solvent induced form changes during high shear wet granulation and drying processes using online raman spectroscopy. Int. J. Pharm. 2018; 541: 253–260

39. Reich, G. Near-Infrared Spectroscopy and imaging: basic principles and pharmaceutical applications. Adv. Drug Deliv. Rev. 2005; 57: 1109–1143.

40. Manley, L.; Hilden, J.; Valero, P.; Kramer, T. Tablet compression force as a process analytical technology (PAT): 100% inspection and control of tablet weight uniformity. J. Pharm. Sci. 2019; 108: 485–493.

41. Clavaud, M.; Lema-Martinez, C.; Roggo, Y.; Bigalke, M.; Guillemain, A.; Hubert, P.; Ziemons, E.; Allmendinger, A. Near-infrared spectroscopy to determine residual moisture in freeze-dried products: model generation by statistical design of experiments. J. Pharm. Sci. 2020; 109: 719–729.

42. Kourti, T. The process analytical technology initiative and multivariate process analysis, monitoring and control. Anal. Bioanal. Chem. 2006; 384: 1043–1048.

43. Antosz, F.J.; Xiang, Y.; Diaz, A.R.; Jensen, A.J. The use of total reflectance x-ray fluorescence (TXRF) for the determination of metals in the pharmaceutical industry. J. Pharm. Biomed. Anal. 2012; 62: 17–22

44. Uo, M.; Wada, T.; Sugiyama, T. Applications of x-ray fluorescence analysis (XRF) to dental and medical specimens. Jpn. Dent. Sci. Rev. 2015; 51: 2–9.

45. Jenkins, R. X-ray fluorescence analysis. In x-ray characterization of materials; John Wiley and sons: Hoboken, NJ, USA, 1999; pp. 171–209.

46. Rodríguez-Hornedo, N.; Murphy, D. Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systems. J. Pharm. Sci. 1999; 88: 651–660.

47. Hansuld, E.M.; Briens, L.; Sayani, A.; Mccann, J.A. Monitoring quality attributes for high-shear wet granulation with audible acoustic emissions. Powder Technol. 2012; 215: 117–123.

Received on 11.06.2025 Revised on 30.07.2025

Accepted on 19.09.2025 Published on 06.11.2025

Available online from November 11, 2025

Asian J. Research Chem.2025; 18(6):420-426.

DOI: 10.52711/0974-4150.2025.00063

This work is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License. Creative Commons License.